Showing results (191-200 of 516) with videos related to
Sort By:
Pageof 52
Breast Cancer Research and Treatment|September 23, 2018
Association between prolonged metastatic free interval and recurrent metastatic breast cancer survival: findings from the SEER databaseEnoch Chang, Sarah S Mougalian, Kerin B Adelson, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 19, 2015
Gamma knife stereotactic radiosurgical thalamotomy for intractable tremor: a systematic review of the literatureAllison M Campbell, Janis Glover, Veronica L S Chiang, et al.Advances in Radiation Oncology|August 12, 2017
A phase 2 trial of salvage radiation and concurrent weekly docetaxel after a rising prostate-specific antigen level after radical prostatectomyWilliam C Jackson, Felix Y Feng, Stephanie Daignault, et al.International Journal of Radiation Oncology, Biology, Physics|April 16, 2003
Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and IIJeff M Michalski, Kathryn Winter, James A Purdy, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 29, 2020
A Randomized Controlled Trial of a 6-Month Low-Carbohydrate Intervention on Disease Progression in Men with Recurrent Prostate Cancer: Carbohydrate and Prostate Study 2 (CAPS2)Stephen J Freedland, Jenifer Allen, Aubrey Jarman, et al.The Prostate|September 30, 2016
Number of Unfavorable Intermediate-Risk Factors Predicts Pathologic Upstaging and Prostate Cancer-Specific Mortality Following Radical Prostatectomy: Results From the SEARCH DatabaseZachary S Zumsteg, Zinan Chen, Lauren E Howard, et al.The Journal of Urology|December 17, 2013
Satisfaction with information used to choose prostate cancer treatmentScott M Gilbert, Martin G Sanda, Rodney L Dunn, et al.International Journal of Radiation Oncology, Biology, Physics|December 25, 2015
Long-Term Outcomes Among Patients Who Achieve Complete or Near-Complete Responses After the Induction Phase of Bladder-Preserving Combined-Modality Therapy for Muscle-Invasive Bladder Cancer: A Pooled Analysis of NRG Oncology/RTOG 9906 and 0233Timur Mitin, Asha George, Anthony L Zietman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02Li-Yan Khor, Kyounghwa Bae, Rebecca Paulus, et al.The New England Journal of Medicine|July 15, 2011
Radiotherapy and short-term androgen deprivation for localized prostate cancerChristopher U Jones, Daniel Hunt, David G McGowan, et al.Pageof 52